On Wednesday Bioelectronics Corp (OTCMCKTS:BIEL) saw less than 8.5 million of their shares getting traded. Yesterday, however, investors were driven into a frenzy and in a single session they were able to shift over 202...
After sitting flat at $0.0014 for three sessions in a row on below-average traded volumes yesterday the stock of Bioelectroncis Corp (OTCMKTS:BIEL) enjoyed far more intense trading. Investors shifted over 150 million shares throughout the...
Bioelectronics Corp. (OTCMKTS:BIEL) managed to add 15% to its market cap on Friday, after bragging that it was featured in an UK mail newspaper health section. Shameless self-promotion seems to be the only means...
Bioelectronics Corp (OTCMKTS:BIEL) published their report for the third quarter of 2015 last week and told us that sales have gone up by about 116% on a year-over-year basis. They also said that the...
Yesterday BioElectronics Corp (OTCMKTS:BIEL) published its quarterly report for the three months ended September 2015. By the closing bell the company’s stock slid 14% down to a close at $0.0012 per share, barely clinging...
If you do some research, you might be able to find one or two things that you like about Bioelectronics Corp (OTCMKTS:BIEL). You might find, for example, that it is a pharmaceutical penny stock...
Bioelectronics Corp. (OTCMKTS:BIEL) had an impressive jump yesterday, but it doesn’t look like this state of developments will last. The last two weeks have been rather exciting for BIEL investors. At last, the ticker’s...
Bioelectronics Corp (OTCMKITS:BIEL) suffered another disastrous session yesterday during which the company lost 23% of its value and closed at $0.001. Sitting at $0.0006 just four sessions ago at least for now the stock...
In just two sessions the stock of Bioelectronics Corp (OTCMKTS:BIEL) managed to move from $0.0006 to a close at $0.002, a massive gain of over 233%. All the commotion was caused by the FDA’s reclassification...
Bioelectronics Corp. (OTCMKTS:BIEL) fully doubled its market cap yesterday, in the most intense trading session it has had in months. The jump seems to have been triggered by the news that the FDA is...